BMY

Bristol-Myers
NYSE

Real-time Quotes | Nasdaq Last Sale

60.19
+1.05
+1.78%
Pre Market: 59.17 -1.02 -1.69% 04:47 07/07 EDT
OPEN
59.60
PREV CLOSE
59.14
HIGH
60.58
LOW
58.87
VOLUME
8.81M
TURNOVER
--
52 WEEK HIGH
68.34
52 WEEK LOW
42.48
MARKET CAP
136.19B
P/E (TTM)
74.40
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 16 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BMY stock price target is 71.36 with a high estimate of 81.00 and a low estimate of 62.00.

EPS

BMY News

More
June 2020 Portfolio Update - Continuing Investments
Seeking Alpha - Article · 19h ago
Dragonfly Therapeutics Reports Research Collaboration With Bristol Myers To Develop Novel Therapeutic Candidates For Multiple Sclerosis, Neuro-Inflammation Target
Benzinga · 20h ago
Top 10 Healthcare Stocks For Dividend Growth And Income
Seeking Alpha - Article · 20h ago
2020 First Half Portfolio Review
Seeking Alpha - Article · 1d ago
Here are Credit Suisse's best stock ideas for the third quarter
Credit Suisse HOLT made list of top stock picks going into the third quarter.
CNBC.com · 2d ago
Bristol-Myers Squibb: Growth And Valuation Trump Other Concerns
Seeking Alpha - Article · 3d ago
Were Hedge Funds Right About Piling Into Bristol Myers Squibb Company (BMY)?
Insider Monkey · 4d ago
iTeos Therapeutics Begins U.S. IPO Rollout
Seeking Alpha - Article · 4d ago

Industry

Pharmaceuticals
+0.74%
Pharmaceuticals & Medical Research
+0.72%

Hot Stocks

Symbol
Price
%Change

About BMY

Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company's products include Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Hepatitis C Franchise, Reyataz Franchise and Sustiva Franchise. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience, and cardiovascular. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world. The Company’s subsidiary is Celgene Corp.
More

Webull offers kinds of Bristol-Myers Squibb Co stock information, including NYSE:BMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BMY stock methods without spending real money on the virtual paper trading platform.